Rockefeller Capital Management L.P. - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 37 filers reported holding AIM IMMUNOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$17
+41.7%
40,0000.0%0.00%
Q4 2022$12
-99.9%
40,0000.0%0.00%
Q3 2022$23,000
-25.8%
40,0000.0%0.00%
Q2 2022$31,000
-26.2%
40,0000.0%0.00%
Q1 2022$42,000
+16.7%
40,0000.0%0.00%
Q4 2021$36,000
-55.0%
40,0000.0%0.00%
Q3 2021$80,000
-7.0%
40,0000.0%0.00%
Q2 2021$86,000
-4.4%
40,0000.0%0.00%
-100.0%
Q1 2021$90,000
+157.1%
40,000
+100.0%
0.00%
Q4 2020$35,000
-18.6%
20,0000.0%0.00%
Q3 2020$43,00020,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
XTX MARKETS LLC 11,019$20,0000.04%
Virtu Financial LLC 103,807$186,0000.02%
ACT WEALTH MANAGEMENT, LLC 10,000$18,0000.01%
SeaCrest Wealth Management, LLC 48,873$87,0000.01%
Arkadios Wealth Advisors 20,000$35,0000.01%
Traynor Capital Management, Inc. 14,777$26,0000.01%
GSA CAPITAL PARTNERS LLP 17,047$31,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 111,000$199,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 20,200$36,0000.00%
Tower Research Capital LLC (TRC) 12,513$22,0000.00%
View complete list of AIM IMMUNOTECH INC shareholders